(Q28247116)

English

Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism

scientific article (publication date: June 2009)

In more languages

Statements

scholarly article

0 references

Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism (English)

0 references

autism spectrum disorder

0 references

0 references

1 reference

based on heuristic

inferred from title

Lisa M Sullivan

object named as

Lisa Sullivan

10

0 references

Lawrence Scahill

object named as

Lawrence Scahill

5

0 references

Evdokia Anagnostou

8

object named as

Evdokia Anagnostou

0 references

2

object named as

Eric Hollander

0 references

author name string

Bryan H King

1

0 references

Linmarie Sikich

3

0 references

James T McCracken

4

0 references

Joel D Bregman

6

0 references

Craig L Donnelly

7

0 references

Kimberly Dukes

9

0 references

Deborah Hirtz

11

0 references

Ann Wagner

12

0 references

Louise Ritz

13

0 references

language of work or name

0 references

publication date

June 2009

0 references

JAMA Psychiatry

0 references

66

0 references

6

0 references

583-90

0 references

Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

20 March 2017

Identification and Evaluation of Children With Autism Spectrum Disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

20 March 2017

Medication Use Among Children with Autism Spectrum Disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

20 March 2017

Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

20 March 2017

Autism diagnostic observation schedule: a standardized observation of communicative and social behavior

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

20 March 2017

The clinical pharmacokinetics of escitalopram

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

29 September 2017

Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

29 September 2017

Treatment outcome and outcome associations in children with pervasive developmental disorders treated with selective serotonin reuptake inhibitors: a chart review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

29 September 2017

An update on pharmacologic treatments for autism spectrum disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

29 September 2017

Placebo effects in developmental disabilities: implications for research and practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

29 September 2017

Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

29 September 2017

Treating functional impairment of autism with selective serotonin-reuptake inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

29 September 2017

Targeted treatments for symptom domains in child and adolescent autism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

29 September 2017

Risperidone in children with autism and serious behavioral problems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

29 September 2017

Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

29 September 2017

Citalopram therapy for depression: a review of 10 years of European experience and data from U.S. clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

29 September 2017

The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

29 September 2017

A case-controlled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

29 September 2017

A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

2 June 2018

The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

2 June 2018

Clinical toxicology of citalopram after acute intoxication with the sole drug or in combination with other drugs: overview of 26 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

27 November 2018

Psychotropic drug prescribing in child and adolescent learning disability psychiatry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

27 November 2018

Restricted and repetitive behaviors in young children with autism spectrum disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

27 November 2018

Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

27 November 2018

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

27 November 2018

A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

27 November 2018

Effect of age and gender on citalopram and desmethylcitalopram steady-state plasma concentrations in adults and elderly depressed patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

27 November 2018

An open-label trial of escitalopram in pervasive developmental disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

27 November 2018

Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

27 November 2018

A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

27 November 2018

Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

27 November 2018

Low-dose fluvoxamine treatment of children and adolescents with pervasive developmental disorders: a prospective, open-label study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

27 November 2018

Use of citalopram in pervasive developmental disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

27 November 2018

A retrospective assessment of citalopram in children and adolescents with pervasive developmental disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

27 November 2018

Clomipramine versus haloperidol in the treatment of autistic disorder: a double-blind, placebo-controlled, crossover study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

27 November 2018

Pharmacotherapy of target symptoms in autistic spectrum disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

27 November 2018

Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

27 November 2018

Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

27 November 2018

The Aberrant Behavior Checklist-Community: factor validity and effect of subject variables for adults in group homes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

27 November 2018

A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4112556

27 November 2018

Identifiers

10.1001/ARCHGENPSYCHIATRY.2009.30

0 references

0 references

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28247116&oldid=1859529034"